SMS Pharma schedules Q4FY26 earnings call on May 27

SMS Pharmaceuticals Ltd has scheduled an investor conference call to discuss its financial results for the fourth quarter and fiscal year ended March 31, 2026. The meeting is set to take place on Wednesday, May 27, 2026, at 11:00 am IST. This session follows the company's announcement of its results on May 22, 2026.

Conference Details

The earnings call will feature senior management from SMS Pharmaceuticals Ltd reviewing the operational and financial performance for the period. Investors and analysts can participate to gain insights into the company's quarterly and annual achievements.

Dial-In Information

Participants can join the call using the universal and international toll-free numbers provided below. Pre-registration is required for the Diamond Pass.

Universal Numbers	Number
	+91 22 6280 1254
	+91 22 7115 8043
International Toll Free Numbers
Hong Kong	800964448
Singapore	8001012045
UK	08081011573
US	18667462133

Contact Information

For further details regarding the conference call or financial results, stakeholders may reach out to the company's compliance officer or investor relations representative.

Company	Investor Relations
SMS Pharmaceuticals Ltd Mr. Thirumalesh Tumma Email: complianceofficer@smspharma.com	Eqspontent Mr. Aditya Dutta Email: smspharma.IR@eqspontent.com

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-10.43%	-4.52%	-6.53%	+35.31%	+45.30%	+148.99%

SMS Pharmaceuticals Limited has initiated the Investor Education and Protection Fund Authority's (IEPFA) "Second 100 Days Campaign- Saksham Niveshak" as part of its compliance and investor protection efforts. The campaign, which runs from April 1, 2026, to July 9, 2026, aims to reach out to shareholders who have not claimed their dividends or need to update their Know Your Customer (KYC) details.

The company has published newspaper advertisements in The Financial Express (English) and Nava Telangana (Telugu) to inform shareholders about this initiative. The campaign specifically targets shareholders with issues related to unclaimed dividends and shares, encouraging them to take necessary action to prevent their dividends and shares from being transferred to the IEPFA.

Campaign Objectives and Shareholder Action

The primary objective of the Saksham Niveshak campaign is to assist shareholders in updating their essential details and claiming their rightful dues. Shareholders are requested to update the following information:

KYC requirements
Bank mandates
Nominee details
Contact information

Shareholders who hold shares in demat form are advised to approach their Depository Participants where they maintain their demat accounts for updating their KYC requirements. Those with physical share holdings or other queries can contact the company's Registrar and Transfer Agent.

Contact Information for Shareholders

Shareholders requiring assistance or wishing to claim unclaimed dividends and update their details can reach out to the designated authorities:

Entity	Contact Details
Registrar and Transfer Agent	Aarthi Consultants Private Limited
Address	1-2-285, Domalguda, Hyderabad - 500029
Phone	040-27638111
Email	info@arthiconsultants.com

The information regarding the campaign has been uploaded on SMS Pharmaceuticals Limited 's website at www.smspharma.com , ensuring easy access for all stakeholders.

Company Details

SMS Pharmaceuticals Limited, with its registered and corporate office located at Plot No. 72, H. No. 8-2-334/3 & 4, Road No. 5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, operates under the Corporate Identity Number L24239TG1987PLC008066. The company's shares are listed on BSE Limited with the security code 532815 and trading symbol SMSPHARMA.

Thirumalesh Tumma, Company Secretary & Compliance Officer of SMS Pharmaceuticals Limited, issued the notice on behalf of the Board of Directors, emphasizing the company's commitment to investor education and protection.